APA (7th ed.) Citation

El Sharkawy, R., Thabet, K., Lampertico, P., Petta, S., Mangia, A., Berg, T., . . . George, J. (2018). A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B. Alimentary Pharmacology & Therapeutics, 48(5), 564. https://doi.org/10.1111/apt.14866

Chicago Style (17th ed.) Citation

El Sharkawy, R., et al. "A STAT4 Variant Increases Liver Fibrosis Risk in Caucasian Patients with Chronic Hepatitis B." Alimentary Pharmacology & Therapeutics 48, no. 5 (2018): 564. https://doi.org/10.1111/apt.14866.

MLA (9th ed.) Citation

El Sharkawy, R., et al. "A STAT4 Variant Increases Liver Fibrosis Risk in Caucasian Patients with Chronic Hepatitis B." Alimentary Pharmacology & Therapeutics, vol. 48, no. 5, 2018, p. 564, https://doi.org/10.1111/apt.14866.